PTThe Paper Trail Project
Sourced institutional rolesLDA lobbying records

BLAIR C LARKINS

BLAIR C LARKINS appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.

Data updated Nov 1, 2026

Source-backed chronology

Career Timeline

Prior government service disclosed in an LDA filing; exact dates not reported

Executive Assistant to Rep. Greg Walden (06-10) Staff Assistant to Rep. Greg Walden (05-06)

Federal government

Inspect source ↗

Federal LDA filings

Lobbying Activity

CVS HEALTH INC2nd Quarter (Apr 1 - June 30) 2021

Registrant: BOCKORNY GROUP, INC. · Pharmacy

Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages HR 1319 American Rescue Plan

LDA filing ↗
CVS HEALTH INC4th Quarter (Oct 1 - Dec 31) 2020

Registrant: BOCKORNY GROUP, INC. · Pharmacy

Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages H.R. 133 Consolidated Appropriations Act, 2021

LDA filing ↗
CVS HEALTH INC1st Quarter (Jan 1 - Mar 31) 2015

Registrant: BOCKORNY GROUP, INC. · Pharmacy

Issues related to prescription drug abuse and drug supply chain safety - no specific legislation Issues related to PBM's - no specific legislation Issues related to preferred pharmacy networks, mail order and incentives

LDA filing ↗
CVS HEALTH INC1st Quarter (Jan 1 - Mar 31) 2015

Registrant: BOCKORNY GROUP, INC. · Health Issues

Issues related to the corporate business model, Medicare Part D and anti-PBM legislation Issues related to health care delivery system reforms, cost containment, medication adherence, restrictions on PBM cost saving tools like mail order, generics and restrictions on PBM audit practices Privacy issues relating to the use of protected health information Issues Related to Telehealth Issues Related to Smoking Cessation Initiatives

LDA filing ↗
CVS HEALTH INC1st Quarter (Jan 1 - Mar 31) 2020

Registrant: BOCKORNY GROUP, INC. · Pharmacy

Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements

LDA filing ↗
CVS HEALTH INC2nd Quarter (Apr 1 - June 30) 2015

Registrant: BOCKORNY GROUP, INC. · Health Issues

H.R.6 - 21st Century Cures Act H.R.793 - Ensuring Seniors Access to Local Pharmacies Act of 2015 H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015 Issues related to the corporate business model, smoking cessation, Medicare Part D and anti-PBM legislation Issues related to health care delivery system reforms including telehealth, cost containment, medication adherence, restrictions on PBM cost saving tools like mail order, generics and restrictions on PBM audit practices Privacy issues relating to the use of protected health information Issues related to Federal Employees Health Benefit Plan Issues related to Medicare/Medicaid plan design, reimbursement, cost savings proposals, and SGR

LDA filing ↗
CVS HEALTH INC2nd Quarter (Apr 1 - June 30) 2015

Registrant: BOCKORNY GROUP, INC. · Pharmacy

Issues related to PBM's - no specific legislation Issues related to preferred pharmacy networks, mail order and incentives Issues related to prescription drug abuse, pharmacist provider status, drug pricing and drug supply chain safety. H.R.1600 - A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. H.R.804 - Expanding the Availability of Medicare Data Act H.R.592 - Pharmacy and Medically Underserved Areas Enhancement Act S.314 - Pharmacy and Medically Underserved Areas Enhancement Act H.R.244 - MAC Transparency Act H.R.1021 - Protecting the Integrity of Medicare Act of 2015 S.776 - Medication Therapy Management Empowerment Act of 2015 H.R.471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015

LDA filing ↗
CVS HEALTH INC3rd Quarter (July 1 - Sep 30) 2015

Registrant: BOCKORNY GROUP, INC. · Pharmacy

Issues related to PBM's - no specific legislation Issues related to preferred pharmacy networks, mail order and incentives Issues related to prescription drug abuse, pharmacist provider status, drug pricing and drug supply chain safety. H.R.1600 - A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. H.R.804 - Expanding the Availability of Medicare Data Act H.R.592 - Pharmacy and Medically Underserved Areas Enhancement Act S.314 - Pharmacy and Medically Underserved Areas Enhancement Act H.R.244 - MAC Transparency Act H.R.1021 - Protecting the Integrity of Medicare Act of 2015 S.776 - Medication Therapy Management Empowerment Act of 2015 H.R.471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015

LDA filing ↗
CVS HEALTH INC3rd Quarter (July 1 - Sep 30) 2015

Registrant: BOCKORNY GROUP, INC. · Health Issues

H.R.6 - 21st Century Cures Act H.R.793 - Ensuring Seniors Access to Local Pharmacies Act of 2015 H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015 Issues related to the corporate business model, smoking cessation, Medicare Part D and anti-PBM legislation Issues related to health care delivery system reforms including telehealth, cost containment, medication adherence, restrictions on PBM cost saving tools like mail order, generics and restrictions on PBM audit practices Privacy issues relating to the use of protected health information Issues related to Federal Employees Health Benefit Plan Issues related to Medicare/Medicaid plan design, reimbursement, cost savings proposals, and SGR Issues related to home infusion

LDA filing ↗
CVS HEALTH INC2nd Quarter (Apr 1 - June 30) 2020

Registrant: BOCKORNY GROUP, INC. · Pharmacy

Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages

LDA filing ↗
CVS HEALTH INC3rd Quarter (July 1 - Sep 30) 2019

Registrant: BOCKORNY GROUP, INC. · Pharmacy

Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements

LDA filing ↗
CVS HEALTH INC4th Quarter (Oct 1 - Dec 31) 2021

Registrant: BOCKORNY GROUP, INC. · Pharmacy

Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages HR 1319 American Rescue Plan

LDA filing ↗
CVS HEALTH INC1st Quarter (Jan 1 - Mar 31) 2021

Registrant: BOCKORNY GROUP, INC. · Pharmacy

Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages H.R. 133 Consolidated Appropriations Act, 2021

LDA filing ↗
CVS HEALTH INC3rd Quarter (July 1 - Sep 30) 2021

Registrant: BOCKORNY GROUP, INC. · Pharmacy

Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages HR 1319 American Rescue Plan

LDA filing ↗
CVS HEALTH INC3rd Quarter (July 1 - Sep 30) 2020

Registrant: BOCKORNY GROUP, INC. · Pharmacy

Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages

LDA filing ↗
CVS HEALTH INC4th Quarter (Oct 1 - Dec 31) 2019

Registrant: BOCKORNY GROUP, INC. · Pharmacy

Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements

LDA filing ↗